AAAAAA

   
Results: 1-5 |
Results: 5

Authors: WURFLEIN D DECHANT M STOCKMEYER B TUTT AL HU PS REPP R KALDEN JR VANDEWINKEL JGJ EPSTEIN AL VALERIUS T GLENNIE M GRAMATZKI M
Citation: D. Wurflein et al., EVALUATING ANTIBODIES FOR THEIR CAPACITY TO INDUCE CELL-MEDIATED LYSIS OF MALIGNANT B-CELLS, Cancer research, 58(14), 1998, pp. 3051-3058

Authors: VALERIUS T WURFLEIN D STOCKMEYER B
Citation: T. Valerius et al., ACTIVATED NEUTROPHILS AS EFFECTOR-CELLS FOR BISPECIFIC ANTIBODIES, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 142-145

Authors: VALERIUS T WURFLEIN D STOCKMEYER B REPP R DEO Y WEINER G KALDEN JR VANDEWINKEL JGJ GLENNIE M GRAMATZKI M
Citation: T. Valerius et al., EVALUATING B-CELL ANTIBODIES FOR THEIR CAPACITY TO MEDIATE ADCC, Blood, 88(10), 1996, pp. 339-339

Authors: VALERIUS T WURFLEIN D ELSASSER D STOCKMEYER B REPP R WEINER G GLENNIE M KALDEN JR VANDEWINKEL JGJ GRAMATZKI M
Citation: T. Valerius et al., EVALUATING B-CELL PANEL ANTIBODIES IN ADCC WITH G-CSF NEUTROPHILS AS EFFECTOR-CELLS, Tissue antigens, 48(4-II), 1996, pp. 111-111

Authors: VALERIUS T REPP R ELSASSER D WURFLEIN D WEINER GJ DEO Y KALDEN JR VANDEWINKEL JJG GLENNIE MJ GRAMATZKI M
Citation: T. Valerius et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF, Blood, 86(10), 1995, pp. 2132-2132
Risultati: 1-5 |